Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis

NCT01318902 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Light-Chain Amyloidosis

Interventions

DRUG: Ixazomib
DRUG: Dexamethasone

Sponsor

Millennium Pharmaceuticals, Inc.